Algonomics announced on July 9 that its anticancer gene therapy platform, "RZ-002," has received a patent registration decision in the United States.
A BREAKTHROUGH jab could turn the clock back on how our immune system ages — and help to tackle cancer and dementia. University College London experts designed the treatment for white blood cells, ...
A BREAKTHROUGH jab could turn the clock back on how our immune system ages — and help to tackle cancer and dementia. University College London experts designed the treatment for white blood cells, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results